Page 373 - FINAL PROGRAMME 2017
P. 373

14:00 - 15:15: Industry sponsored symposium: MSD
14:00 - 14:05 14:05 - 14:20 14:20 - 14:45 14:45 - 15:10 15:10 - 15:15
Re-evaluating success in ART: Useful measures in optimizing patient outcomes
Chair
Peter Humaidan, Denmark
Chairman’s welcome and opening remarks
Peter Humaidan, Denmark
De ning success in ART
Peter Humaidan, Denmark
Preimplantation genetic diagnosis for aneuploidy (PGD-A) in the clinical setting
Richard Scott, U.S.A.
Ovarian stimulation and cumulative live birth rates
Nikolaos P. Polyzos, Spain
Closing remarks
Peter Humaidan, Denmark
16:30 - 17:30: Industry sponsored session: Thermo Fisher Scienti c
16:30 - 17:00 17:00 - 17:30
New solutions for high throughput analysis of mosaicism and translocations in preimplantation samples
Unbalanced products of reciprocal translocation detection using Ion PGMTM System and Ion ReporterTM Software
Sebastian Pukszta, Poland
High throughput analysis of preimplantation and mosaic samples: pilot experiment results using the Ion ReproSeqTM PGS Kits for the Ion S5TM System
Fabien Murisier, Switzerland
Marta Cotado, Switzerland
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 373
ACKNOWLEDGEMENTS


































































































   371   372   373   374   375